CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| City of Hope, Beckman Research Institute |
Richard Jove |
Conference |
New Approaches in Cell Based Therapies |
$20,000 |
| University of California, San Francisco |
Dr. Brian Black |
Conference |
Weinstein Cardiovascular Development Conference |
$35,000 |
| City of Hope, Beckman Research Institute |
Fouad R Kandeel |
Conference |
2012 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research |
$15,000 |
| City of Hope, Beckman Research Institute |
Fouad R Kandeel |
Conference |
2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research |
$15,000 |
| City of Hope, Beckman Research Institute |
Fouad R Kandeel |
Conference |
2013 Rachmiel Diabetes and Obesity Levine Symposium – Advances in Diabetes Research |
$27,750 |
| City of Hope, Beckman Research Institute |
Fouad R Kandeel |
Conference |
2009 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Biology, Immunology and Cell Therapy |
$15,000 |
| Stanford University |
Dr. Thomas A. Rando |
Conference |
Keystone Symposia, ‘The Life of a Stem Cell: From Birth to Death’ |
$50,000 |
| California Institute of Technology |
Paul H. Patterson |
Conference |
World Stem Cell Summit |
$50,000 |
| Children’s Hospital of Orange County |
Philip Schwartz Ph.D. |
Conference |
Stem Cell Therapies for Pediatric Diseases and Injuries: A Critial Evaluation |
$786 |
| Gladstone Institutes, J. David |
Dr. Steve M. Finkbeiner |
Conference |
THE 5TH ANNUAL CALIFORNIA ALS PAC10 AND RESEARCH NETWORK MEETING |
$9,529 |
| University of California, Irvine |
Dr. Michelle Khine |
Conference |
UC Systemwide Bioengineering Symposium |
$7,525 |
| Biocom California Institute |
Jennifer Landress |
Conference |
The 2014 BIO International Convention |
$50,000 |
| Stanford University |
Dr. Joseph C. Wu |
Conference |
Cardiovascular Regenerative Medicine Symposium |
$9,000 |
| University of California, San Francisco |
Jason R. Rock |
Conference |
Tri-Institutional Stem Cell Retreat |
$3,500 |
| University of California, San Francisco |
Dr. Tippi C. MacKenzie |
Conference |
In Utero Hematopoietic Stem Cell Transplantation and Maternal-Fetal Tolerance |
$17,526 |
| Stanford University |
Dr. Fan Yang PhD |
Conference |
2014 Materials Research Society (MRS) Spring Meeting:
Symposium Y: Biomaterials for Biomolecule Delivery and Understanding Cell-Niche Interactions |
$10,000 |
| Human Organ Project |
Anita Caufield |
Conference |
Regenerative Medicine Foundation 2014 Conference |
$50,000 |
| University of California, San Francisco |
Jeffrey Rosenfeld |
Conference |
California ALS Research Summit 2014 |
$8,563 |
| University of California, Davis |
Dr. Mark Yarborough PhD |
Conference |
Stem Cell Research for Neurological Disorders: A Case Study in Ethical and Policy Issues in ALS Research |
$1,020 |
| University of California, San Francisco |
Regis Kelly |
Conference |
The Science of Staying Younger Longer |
$6,500 |
| Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Conference |
Keystone Symposia, “Stem Cells and Reprogramming” |
$50,000 |
| Sanford Consortium for Regenerative Medicine |
Dr. Edward Holmes |
Conference |
The Sanford Consortium for Regenerative Medicine’s Scientific Symposium and the Regen Med Partnering Forum at Stem Cell Meeting on the Mesa VIII |
$35,000 |
| University of California, San Francisco |
Dr. Susan J Fisher PhD |
Conference |
The Stem Cell Niche in Development and Disease |
$5,000 |
| University of California, San Francisco |
Dr. Peter G. Stock |
Conference |
IPITA 2013 – 14th World Congress of the International Pancreas and Islet transplant Association |
$10,000 |
| University of California, Los Angeles |
Dr. Dana Leanne Jones |
Conference |
7th CA/HSCI Junior PI Conference: Stem Cells 2.0 |
$2,500 |
| Stanford University |
Dr. Thomas A. Rando |
Conference |
Third Annual Symposium on Regenerative Rehabilitation |
$20,000 |
| OCTANe Foundation for Innovation |
Matthew Jenusaitis |
Conference |
Orange County Summit on Regenerative Medicine (OCSRM) |
$2,500 |
| Alliance Forum Foundation |
George Hara |
Conference |
2013 World Alliance Forum in San Francisco |
$3,500 |
| University of California, San Diego |
Joan Brown |
Conference |
International Society for Heart Research (ISHR) XX1 World Congress |
$10,000 |
| Scripps Research Institute |
Dr. Jeanne F Loring |
Conference |
World Stem Cell Summit |
$30,000 |
| University of California, Davis |
Dr. Alice F Tarantal |
Conference |
12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases |
$8,000 |
| Stanford University |
Dr. Julien Sage |
Conference |
3rd International RB conference |
$10,000 |
| Lineage Cell Therapeutics, Inc. |
Francois Binette |
Strategic Partnership III Track A |
A Phase I/IIa Dose Escalation Safety Study of AST-OPC1 in Patients with Cervical Sensorimotor Complete Spinal Cord Injury |
$14,323,318 |
| City of Hope, Beckman Research Institute |
Prof. John A. Zaia |
Strategic Partnership III Track A |
A Phase I, Open-Label Study To Assess The Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) with Escalating Doses of Busulfan In HIV-1 (R5) Infected Sub… |
$5,583,438 |
| University of California, Santa Cruz |
Dr. Joshua M Stuart |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics – UCSC |
$3,999,083 |
| Salk Institute for Biological Studies |
Dr. Joseph R Ecker |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics – Salk |
$13,201,635 |
| Stanford University |
Dr. Michael P Snyder PhD |
Genomics Centers of Excellence Awards (R) |
Center of Excellence for Stem Cell Genomics – Stanford |
$22,787,914 |
| Scribe Therapeutics |
Brett Staahl |
Preclinical Stage Projects |
A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent
Cardiovascular Events |
$12,714,480 |
| 4D Molecular Therapeutics, Inc. |
Sara Collins |
Preclinical Stage Projects |
Gene Therapy for Alpha-1 Anti-Trypsin Deficiency |
$5,915,073 |
| AcuraStem Incorporated |
Mr. Samuel V. Alworth MS, MBA |
Preclinical Stage Projects |
Late-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies |
$7,500,000 |
| Cure Rare Disease |
Dr. Tahseen Mozaffar |
Preclinical Stage Projects |
Advancement of a myotropic, liver-detargeting therapy for LGMD2i/R9 |
$7,292,297 |
| Scribe Therapeutics |
Brett Staahl |
Preclinical Stage Projects |
A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia |
$13,000,000 |
| Savanna Biotherapeutics, Inc. |
Dr. Sunil Gandhi Ph.D |
Preclinical Stage Projects |
Microglia replacement therapy for CSF1R-related Leukoencephalopathy |
$12,993,456 |
| Cedars-Sinai Medical Center |
Dr. David Joseph Lefer |
Preclinical Stage Projects |
TY1 and Semaglutide to Treat Cardiometabolic HFpEF |
$10,571,220 |
| University of California, San Diego |
Dr. Stephanie Cherqui |
Preclinical Stage Projects |
CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia |
$7,423,504 |
| Cedars-Sinai Medical Center |
Dr. Alessandra Ciullo |
Preclinical Stage Projects |
Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy |
$10,419,929 |
| Navega Therapeutics |
Ana Maria Moreno |
Preclinical Stage Projects |
Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders |
$9,486,864 |
| Scripps Health |
Dr. Darryl D. D’Lima |
Preclinical Stage Projects |
Stem Cell-Based Cartilage Tissue Regeneration |
$12,715,000 |
| Stanford University |
Dr. Bertha Chen |
Preclinical Stage Projects |
Autologous iPSC-derived progenitor smooth muscle cells for treatment of urinary incontinence |
$7,275,596 |
| Loma Linda University |
Hisham Abdel-Azim |
CCCE Grant |
Inland Empire and Desert Region CIRM Community Care Center of Excellence |
$9,000,000 |
